Relation of Plasma Obestatin Levels with BMI and HOMA-IR in Syrian Obese Patients with Type 2 Diabetes

Alhalbouni, Hiba; Kabalan, Y; Al-Quobaili, Faizeh

doi:10.2174/1874944501710010132

Cited by 1 publication

(1 citation statement)

References 20 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrary to our data, Alhalbouni et al, [56] reported that OBST levels were significantly lower in patients with T2DM, and no correlation was found between its level and inflammatory markers in two chronic inflammatory diseases RA and BD.…”

Section: Resultscontrasting

confidence: 99%

Evaluation of Serum Obestatin Level in Rat Model of Diabetic Nephropathy

Khalil¹,

Raafat²

2018

The Medical Journal of Cairo University

View full text Add to dashboard Cite

Background: Diabetic nephropathy is characterized by excessive protienuria and progressive irreversible renal damage. Various mechanisms were suspected to the development of diabetic nephropathy. However, a few studies have reported associations between obestatin and diabetic complications. Aim of the Work:To evaluate serum OBST in type II diabetic nephropathy rat model and the possible association with the different biochemical and renal parameters.Material and Methods: Twenty male albino rats were included in the study and divided into two groups: Group (I): Control group, group (II) type II diabetic group rats were fed High Fat Diet (HFD) for 5wks, then the HFD was replaced with normal rodent diet and animals received single intraperitoneal injection of low dose of Streptozotocin (STZ) (35mg/kg). However, rats had been followed up for two weeks (group IIa), four weeks (group IIb) and for eight weeks (group IIc) after induction of diabetes, the following parameters were examined BMI, mean arterial blood pressure, serum OBST, insulin, glucose and calculated insulin resistance, lipids profile, tumor necrosis factor-alpha, angiotensin II levels, urea, creatinine and uric acid. Proteinuria, glomerular filtration rate and renal malondialdhyde level, glutathione peroxidase and superoxide dismutase activities. Histopathological examinations for kidney tissues were also done at the end of experiment.Results: There were a significant progressive increase in serum levels of OBST, TNF-a and MAP in group II (a, b, c levels) and progressive increase in serum urea, creatinen, UA, ANG II and proteinuria in group IIb and c levels while, group IIa showed insignificant changes. In addition, there were a significant increase in serum glucose, HOMA-IR, total cholesterol, TG, LDL, VLDL and renal MDA, with a significant decrease in serum insulin, HDL, GFR and renal GSH-Px, SOD activities in group IIc level. Moreover, there was a progressive significant decrease in BMI in group II (b and c levels). Furthermore, obestatin levels were positively correlated with all the previously affected parameters in group II at all levels, except with insulin, HDL and GFR which showed a significant negative correlation. While no significant correlation had been found with GSH-Px, SOD activities. Egypt Conclusion: Serum OBST levels were significantly elevated in experimentally induced diabetic nephropathy in rats and positively correlated with most of the measured biochemical and renal parameters except for insulin, HDL-C and GFR was negatively correlated. These findings simplify that OBST can be used as a novel biomarker for diabetes induced complications. As its increase may play a compensatory role in this metabolic disturbance.

show abstract

Section: Resultscontrasting

confidence: 99%